Recruiting Pulmonary Fibrosis Studies in Charleston
About Pulmonary Fibrosis Clinical Trials in Charleston
Pulmonary fibrosis is a condition in which the lung tissue becomes damaged and scarred, making it difficult for the lungs to function properly. Idiopathic pulmonary fibrosis (IPF) is the most common form with unknown cause. Antifibrotic medications can slow progression, and lung transplant may be considered.
There are currently 3 pulmonary fibrosis clinical trials recruiting participants in Charleston, WV. These studies are seeking a combined 274 participants. Research is being sponsored by Medical University of South Carolina, Boehringer Ingelheim, Mannkind Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Fibrosis Clinical Trials in Charleston — FAQ
Are there pulmonary fibrosis clinical trials in Charleston?
Yes, there are 3 pulmonary fibrosis clinical trials currently recruiting in Charleston, WV. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Charleston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Charleston research site will contact you about next steps.
Are clinical trials in Charleston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Charleston studies also compensate for your time and travel.
What pulmonary fibrosis treatments are being tested?
The 3 active trials in Charleston are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary fibrosis.
Data updated July 13, 2026 from ClinicalTrials.gov